Eli Lilly&Company CEO John Lechleiter to retire; David Ricks to succeed

By: | Updated: July 27, 2016 5:22 PM

Eli Lilly and Co said on Wednesday Chief Executive John Lechleiter would retire by the end of the year and would be succeeded by senior vice president David Ricks on January 1.

Lilly on Tuesday reported better-than-expected quarterly sales, fueled by newer drugs, and predicted average annual revenue growth of at least 5 percent through the end of the decade due to its growing roster of medicines. (Reuters)Eli Lilly&Co on Tuesday reported better-than-expected quarterly sales, fueled by newer drugs, and predicted average annual revenue growth of at least 5 percent through the end of the decade due to its growing roster of medicines. (Reuters)

Eli Lilly and Co said on Wednesday Chief Executive John Lechleiter would retire by the end of the year and would be succeeded by senior vice president David Ricks on January 1.

Lechleiter joined Lilly in 1979 as a senior organic chemist, and became the CEO in April 2008.

Lilly on Tuesday reported better-than-expected quarterly sales, fueled by newer drugs, and predicted average annual revenue growth of at least 5 percent through the end of the decade due to its growing roster of medicines.

The Indianapolis drugmaker’s earnings growth resumed last year after three years of tumbling sales caused by competition from generic drugs.

Get live Stock Prices from BSE and NSE and latest NAV, portfolio of Mutual Funds, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Switch to Hindi Edition